fda warning bpc-157 compounding just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank BPC-157 Legal Status: FDA Regulations

[1] A secondary and post-hoc analysis of the same trial also reported clinically relevant reductions in blood pressure

You may need ongoing treatments to maintain your results and enjoy the full benefits of peptide therapy

Cagrilintide and semaglutide are not competitors they are complements

Hydroxocobalamin is often used by clinicians to treat B12 deficiency as it is retained in the body for longer than other forms

Acknowledgements This study was supported in part by the Intramural Research Program of the National Center for Advancing Translational Sciences, National Institutes of Health

(11) Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin blend is available for research and laboratory purposes only